Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€143.70
01.12.23
€163.56
01.12.24
6.77%
09:15

Royal Bank of Canada 
01.12.23 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€143.60
01.12.23
€165.58
01.12.24
6.85%
09:15

UBS Group AG 
01.12.23 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€131.40
01.12.23
€166.50
01.12.24
36.90%
09:04

Raymond James 
01.12.23 50%
buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€93.20
01.12.23
€110.39
01.12.24
34.74%
09:23

Cantor Fitzgerald 
01.12.23 50%
buy
Veeva Systems A

Start price
Target price
Perf. (%)
€160.30
01.12.23
-
01.12.24
22.02%
02.09.24

stw 
01.12.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€509.00
30.11.23
€559.92
30.11.24
5.76%
08:54

Truist Financial Co. 
30.11.23 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€19.62
30.11.23
-
30.11.24
12.62%
08.12.23

Could be very worthwhile Investment >20% year
thomasw 
30.11.23 50%
buy
Patterson Companies Inc.

Start price
Target price
Perf. (%)
€23.20
30.11.23
€31.22
30.11.24
-9.99%
29.08.24

Piper Sandler 
30.11.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€501.00
30.11.23
€546.23
30.11.24
7.45%
08:54

Royal Bank of Canada 
30.11.23 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€22.00
30.11.23
€45.85
30.11.24
9.55%
09:14

Royal Bank of Canada 
30.11.23 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€493.00
30.11.23
€535.86
30.11.24
9.19%
08:54

Stephens 
30.11.23 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.54
30.11.23
-
30.11.24
-65.13%
12.08.24

StockNews.com 
30.11.23 50%
buy
Blueprint Medicines Corp

Start price
Target price
Perf. (%)
€64.00
30.11.23
-
30.11.24
10.94%
31.01.24

Saftman 
30.11.23 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€48.47
29.11.23
€82.82
29.11.24
22.14%
09:22

Truist Financial Co. 
29.11.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€540.50
29.11.23
€591.57
29.11.24
61.24%
09:21

Truist Financial Co. 
29.11.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€243.40
29.11.23
€291.23
29.11.24
26.23%
09:11

Truist Financial Co. 
29.11.23 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€91.50
29.11.23
€123.00
29.11.24
19.48%
09:24

Cantor Fitzgerald 
29.11.23 50%
sell
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€35.60
29.11.23
-
29.11.24
44.66%
02.09.24

StockNews.com 
29.11.23 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.54
29.11.23
-
29.11.24
-23.36%
21.03.24

StockNews.com 
29.11.23 50%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.92
29.11.23
€3.64
29.11.24
51.63%
30.08.24

BTIG Research 
29.11.23 50%
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€0.39
29.11.23
€19.13
29.11.24
-
20.11.23

HC Wainwright 
29.11.23 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€104.55
29.11.23
€205.00
29.11.24
1.39%
02.09.24

Needham & Company LLC 
29.11.23 50%
buy
Atricure Inc.

Start price
Target price
Perf. (%)
€59.50
29.11.23
€44.64
29.11.24
-
30.09.21

Needham & Company LLC 
29.11.23 50%
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.36
29.11.23
€2.00
29.11.24
3.49%
02.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Traumtanz 
29.11.23 50%
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€5.80
29.11.23
-
29.11.24
-28.62%
25.05.24

Could be very worthwhile Investment >20% year
blaugold 
29.11.23 50%